2019 Social Anxiety Disorders (SAD) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 82 pages | ID: 27E847E0F91EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Social Anxiety Disorders (SAD) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Social Anxiety Disorders (SAD). It presents in-depth analysis of Social Anxiety Disorders (SAD) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Social Anxiety Disorders (SAD).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Social Anxiety Disorders (SAD) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Social Anxiety Disorders (SAD)

The research work is prepared through extensive and continuous research on Social Anxiety Disorders (SAD) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Social Anxiety Disorders (SAD) patients are identified
• The report includes panorama of Social Anxiety Disorders (SAD) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Social Anxiety Disorders (SAD) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Social Anxiety Disorders (SAD) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Social Anxiety Disorders (SAD) Clinical Trials by Region
  2.2.2 Average Enrollment of Social Anxiety Disorders (SAD) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Social Anxiety Disorders (SAD) Treatment, 2019

3. REGION WISE SOCIAL ANXIETY DISORDERS (SAD) CLINICAL TRIALS

3.1 Asia Pacific Social Anxiety Disorders (SAD) Clinical Trials by Country
3.2 Europe Social Anxiety Disorders (SAD) Clinical Trials by Country
3.3 North America Social Anxiety Disorders (SAD) Clinical Trials by Country
3.4 Middle East and Africa Social Anxiety Disorders (SAD) Clinical Trials by Country
3.5 South and Central America Social Anxiety Disorders (SAD) Clinical Trials by Country

4. SOCIAL ANXIETY DISORDERS (SAD) CLINICAL TRIAL TRENDS

4.1 Start Year wise Social Anxiety Disorders (SAD) Clinical Trials
4.2 Phase wise Social Anxiety Disorders (SAD) Clinical Trials
4.3 Trial Status wise Social Anxiety Disorders (SAD) Clinical Trials
4.4 Trial Type wise Social Anxiety Disorders (SAD) Clinical Trials

5. SOCIAL ANXIETY DISORDERS (SAD) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Social Anxiety Disorders (SAD) Trials by Year
5.2 Average Enrollment in Social Anxiety Disorders (SAD) Trials by Phase
5.3 Average Enrollment in Social Anxiety Disorders (SAD) Trials by Status
5.4 Average Enrollment in Social Anxiety Disorders (SAD) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN SOCIAL ANXIETY DISORDERS (SAD) CLINICAL TRIALS

6.1 Social Anxiety Disorders (SAD) Trials by Sponsor Type
6.2 Social Anxiety Disorders (SAD) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Social Anxiety Disorders (SAD) Trials- Phase
7.2 Social Anxiety Disorders (SAD) Trials- Phase
7.3 Social Anxiety Disorders (SAD) Trials- Phase
7.4 Social Anxiety Disorders (SAD) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Social Anxiety Disorders (SAD) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Social Anxiety Disorders (SAD) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Social Anxiety Disorders (SAD) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Social Anxiety Disorders (SAD) Clinical Trials and Enrolment
Figure 7: North America – Country wise Social Anxiety Disorders (SAD) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Social Anxiety Disorders (SAD) Clinical Trials and Enrolment
Figure 9: Social Anxiety Disorders (SAD) Clinical Trials by Phase
Figure 10: Social Anxiety Disorders (SAD) Clinical Trials by Trial Status
Figure 11: Social Anxiety Disorders (SAD) Clinical Trials by Type
Figure 12: Social Anxiety Disorders (SAD) Clinical Trials by Sponsor Type
Figure 13: Social Anxiety Disorders (SAD) Clinical Trials by Leading Sponsors
Figure 14: Social Anxiety Disorders (SAD) Average Enrollment by Phase
Figure 15: Social Anxiety Disorders (SAD) Average Enrollment by Trial Status
Figure 16: Social Anxiety Disorders (SAD) Average Enrollment by Type
Figure 17: Social Anxiety Disorders (SAD)- Average Enrolment by Type of Sponsors
Figure 18: Social Anxiety Disorders (SAD)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Social Anxiety Disorders (SAD) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Social Anxiety Disorders (SAD) Clinical Trials and Enrolment
Table 5: Europe – Country wise Social Anxiety Disorders (SAD) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Social Anxiety Disorders (SAD) Clinical Trials and Enrolment
Table 7: North America – Country wise Social Anxiety Disorders (SAD) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Social Anxiety Disorders (SAD) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Social Anxiety Disorders (SAD) Average Enrollment by Phase
Table 15: Social Anxiety Disorders (SAD) Average Enrollment by Trial Status
Table 16: Social Anxiety Disorders (SAD) Average Enrollment by Type
Table 17: Social Anxiety Disorders (SAD)- Average Enrolment by Type of Sponsors
Table 18: Social Anxiety Disorders (SAD)- Enrolment by Leading Sponsors